advertisement
Galanopoulos A 22
Showing records 1 to 22 | Display all abstracts from Galanopoulos A126854 Topical brinzolamide-induced ciliary body effusion with secondary angle closure and myopic shift
Guymer C
British Medical Journal (Clinical Research Edition) Case Reports 2025; 18:
126986 A Multitrait Open-Angle Glaucoma Polygenic Risk Score Stratifies Risk of Glaucoma Diagnosis and Severity in Eyes with Pseudoexfoliation
Kolovos A
Ophthalmology 2025; 0:
125145 Comparative Study of Early Safety and Effectiveness Outcomes of the PreserFlo MicroShunt with and without an Intraluminal Suture Stent
Chami J
Ophthalmology. Glaucoma 2025; 0:
126986 A Multitrait Open-Angle Glaucoma Polygenic Risk Score Stratifies Risk of Glaucoma Diagnosis and Severity in Eyes with Pseudoexfoliation
Kolovos A
Ophthalmology 2025; 0:
126854 Topical brinzolamide-induced ciliary body effusion with secondary angle closure and myopic shift
Galanopoulos A
British Medical Journal (Clinical Research Edition) Case Reports 2025; 18:
126986 A Multitrait Open-Angle Glaucoma Polygenic Risk Score Stratifies Risk of Glaucoma Diagnosis and Severity in Eyes with Pseudoexfoliation
Qassim A
Ophthalmology 2025; 0:
125145 Comparative Study of Early Safety and Effectiveness Outcomes of the PreserFlo MicroShunt with and without an Intraluminal Suture Stent
Tan JCK
Ophthalmology. Glaucoma 2025; 0:
126986 A Multitrait Open-Angle Glaucoma Polygenic Risk Score Stratifies Risk of Glaucoma Diagnosis and Severity in Eyes with Pseudoexfoliation
Hassall MM
Ophthalmology 2025; 0:
125145 Comparative Study of Early Safety and Effectiveness Outcomes of the PreserFlo MicroShunt with and without an Intraluminal Suture Stent
Manning D
Ophthalmology. Glaucoma 2025; 0:
126986 A Multitrait Open-Angle Glaucoma Polygenic Risk Score Stratifies Risk of Glaucoma Diagnosis and Severity in Eyes with Pseudoexfoliation
Marshall HN
Ophthalmology 2025; 0:
125145 Comparative Study of Early Safety and Effectiveness Outcomes of the PreserFlo MicroShunt with and without an Intraluminal Suture Stent
Kong G
Ophthalmology. Glaucoma 2025; 0:
126986 A Multitrait Open-Angle Glaucoma Polygenic Risk Score Stratifies Risk of Glaucoma Diagnosis and Severity in Eyes with Pseudoexfoliation
Schmidt J
Ophthalmology 2025; 0:
125145 Comparative Study of Early Safety and Effectiveness Outcomes of the PreserFlo MicroShunt with and without an Intraluminal Suture Stent
Cheng J; Dunn H
Ophthalmology. Glaucoma 2025; 0:
126986 A Multitrait Open-Angle Glaucoma Polygenic Risk Score Stratifies Risk of Glaucoma Diagnosis and Severity in Eyes with Pseudoexfoliation
Nguyen TT
Ophthalmology 2025; 0:
125145 Comparative Study of Early Safety and Effectiveness Outcomes of the PreserFlo MicroShunt with and without an Intraluminal Suture Stent
Dunn H; Galanopoulos A
Ophthalmology. Glaucoma 2025; 0:
126986 A Multitrait Open-Angle Glaucoma Polygenic Risk Score Stratifies Risk of Glaucoma Diagnosis and Severity in Eyes with Pseudoexfoliation
He W; Mullany S
Ophthalmology 2025; 0:
125145 Comparative Study of Early Safety and Effectiveness Outcomes of the PreserFlo MicroShunt with and without an Intraluminal Suture Stent
Chua B; Thai J
Ophthalmology. Glaucoma 2025; 0:
126986 A Multitrait Open-Angle Glaucoma Polygenic Risk Score Stratifies Risk of Glaucoma Diagnosis and Severity in Eyes with Pseudoexfoliation
Hollitt GL
Ophthalmology 2025; 0:
125145 Comparative Study of Early Safety and Effectiveness Outcomes of the PreserFlo MicroShunt with and without an Intraluminal Suture Stent
Hassall M
Ophthalmology. Glaucoma 2025; 0:
126986 A Multitrait Open-Angle Glaucoma Polygenic Risk Score Stratifies Risk of Glaucoma Diagnosis and Severity in Eyes with Pseudoexfoliation
Berry EC; Tang V
Ophthalmology 2025; 0:
125145 Comparative Study of Early Safety and Effectiveness Outcomes of the PreserFlo MicroShunt with and without an Intraluminal Suture Stent
Craig JE; Lawlor M
Ophthalmology. Glaucoma 2025; 0:
126986 A Multitrait Open-Angle Glaucoma Polygenic Risk Score Stratifies Risk of Glaucoma Diagnosis and Severity in Eyes with Pseudoexfoliation
Zhou T; Lake S; Mills R; Landers J; Casson RJ; Galanopoulos A; Graham SL; Schulz A; Healey PR; Mitchell P; Goldberg I; Grigg J; Ruddle J; Mackey DA; Burdon KP; Hewitt AW; Seviiri M; Gharahkhani P; Souzeau E; Siggs OM; Macgregor S; Craig JE
Ophthalmology 2025; 0:
